ALGN (Align Technology) Risk Assessment

View and export this data going back to 2001. Start your Free Trial

What is Align Technology Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Align Technology is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Align Technology's Risk Assessment

For the Medical Instruments & Supplies subindustry, Align Technology's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Align Technology's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Align Technology's Risk Assessment falls into.

Align Technology (NAS:ALGN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Align Technology Risk Assessment Related Terms

Thank you for viewing the detailed overview of Align Technology's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (NAS:ALGN) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

ALGN:Mexico 0HCK:UK AFW:Germany AFW:Germany A1LG34:Brazil ALGN:Austria

Address

410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288

Website

https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Executives

Larkin C Raymond Jr	director	C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Joseph Lacob	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Emory Wright	officer: VP, Operations	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Joseph M Hogan	director, officer: President and CEO	C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Kevin J Dallas	director	C/O ALIGN TECHNOLOGY INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95134
John Morici	officer: Chief Financial Officer	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Warren S Thaler	director	C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Anne Myong	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95141
Julie Ann Coletti	officer: SVP, Chief Legal & Regulatory	2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Greg J Santora	director	4201 GRANT COURT, PLEASANTON CA 94566
Stuart A Hockridge	officer: VP, Global Human Resources	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
George J Morrow	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Andrea Lynn Saia	director	C/O COCA-COLA ENTERPRISES, INC., 2500 WINDY RIDGE PARKWAY, NW, 14TH FLOOR, ATLANTA GA 30339
Thomas M Prescott	director	C/O ALIGN TECHNOLOGY INC, 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Yuval Shaked	officer: SVP and Mgng Director, Itero	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134